The Journal of
Clinical Psychiatry

Neurology Dementia

Letter to the Editor July 1, 2003

Reply to Olanzapine/Risperidone and Diabetes Risk

Frank D. Gianfrancesco

J Clin Psychiatry 2003;64(7):848-848

Article Abstract

Letter to the Editor

Reply to Olanzapine/Risperidone and Diabetes Risk

Download Free PDF

This PDF is free for all visitors!

Save

Cite

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia

Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Vol 86 • 2025 • Number 2

Read the Current Issue

Original Research

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Original Research

Valbenazine in Elderly Adults With Tardive Dyskinesia

Academic Highlights

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Original Research

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Brief Report

Psychosocial Correlates of Optimism among US Military Veterans

View current Issue

Related Articles

Why Ask Patients to Cut Into Quarters 10 mg THC Gummies From a Dispensary When 2.5 mg THC Is Available by Prescription?

Letter to the Editor

Why Ask Patients to Cut Into Quarters 10 mg THC Gummies From a Dispensary When 2.5 mg THC Is Available by Prescription?

June 5, 2024

The authors discuss a study by Sawicki et al of dementia patients for whom 2.5 mg of THC was recommended for neuropsychiatric symptoms.

Marina Goldman , Dimitri Markov

THC Edible Gummies for Behavioral Symptoms of Dementia: Reply to Goldman and Markov

Letter to the Editor

THC Edible Gummies for Behavioral Symptoms of Dementia: Reply to Goldman and Markov

June 5, 2024

The authors reply to Goldman and Markov’s comments on their recent study of dispensary-obtained THC for dementia.

Cristian Hernandez , Erin K. Zahradnik

Insights Into Poststroke Depression

Letter to the Editor

Insights Into Poststroke Depression

August 31, 2023

The authors shed light on risk factors, purported mechanisms, diagnostic tips, and treatment options for poststroke depression.

Ahmed Naguy , Bibi Alamiri